Empirical Finance, LLC Gilead Sciences, Inc. Transaction History

Empirical Finance, LLC

$1.62 Billion
Q1 2024

A detailed history of Empirical Finance, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Empirical Finance, LLC holds 45,447 shares of GILD stock, worth $3.3 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

45,447

Previous 43,709 3.98%

Holding current value

$3.3 Million

Previous $3.28 Million 1.62%

% of portfolio

0.21%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $124,406 - $151,710	1,738 Added 3.98%	45,447 $3.33 Million
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $326,075 - $355,754	4,410 Added 11.22%	43,709 $3.28 Million
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $326,614 - $372,549	4,297 Added 12.28%	39,299 $3.03 Million
Q1 2023 Apr 05, 2023	BUY	$77.31 - $88.08 $132,354 - $150,792	1,712 Added 5.14%	35,002 $2.9 Million
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $166,955 - $239,690	2,679 Added 8.75%	33,290 $2.86 Million

Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $294,842 - $336,785	4,952 Added 19.3%	30,611 $1.89 Million
Q2 2022 Aug 01, 2022	BUY	$57.72 - $65.01 $78,903 - $88,868	1,367 Added 5.63%	25,659 $1.59 Million
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $154,762 - $193,933	2,672 Added 12.36%	24,292 $1.44 Million
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $372,216 - $422,472	5,737 Added 36.12%	21,620 $1.57 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $538,135 - $580,588	-7,950 Reduced 33.36%	15,883 $1.11 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $312,335 - $341,271	-4,921 Reduced 17.11%	23,833 $1.64 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $126,556 - $144,204	2,234 Added 8.42%	28,754 $1.68 Million
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $676,331 - $850,369	-10,891 Reduced 29.11%	26,520 $1.68 Million
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $795,811 - $1 Million	12,815 Added 52.1%	37,411 $2.37 Million
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $250,875 - $291,312	-3,468 Reduced 15.0%	19,647 $1.89 Million
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $358,010 - $415,716	4,949 Added 25.19%	24,596 $1.89 Million
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $754,378 - $966,249	-12,045 Reduced 34.26%	23,115 $1.73 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $138,706 - $152,572	-2,251 Reduced 6.02%	35,160 $2.29 Million
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $42,381 - $46,782	-678 Reduced 1.78%	37,411 $2.37 Million
Q2 2019 Jul 09, 2019	BUY	$61.87 - $69.38 $15,281 - $17,136	247 Added 0.65%	38,089 $2.57 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $96,921 - $108,577	1,550 Added 4.27%	37,842 $2.46 Million
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $16,345 - $21,330	-270 Reduced 0.74%	36,292 $2.27 Million
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $1.48 Million - $1.64 Million	20,749 Added 131.21%	36,562 $2.82 Million
Q2 2018 Jul 09, 2018	SELL	$64.88 - $75.68 $1.43 Million - $1.67 Million	-22,029 Reduced 58.21%	15,813 $1.12 Million
Q1 2018 May 10, 2019	BUY	$72.84 - $88.8 $850,188 - $1.04 Million	11,672 Added 44.6%	37,842 $2.46 Million
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $868,252 - $1.06 Million	11,920 Added 83.65%	26,170 $1.97 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $1.36 Million - $1.6 Million	-19,144 Reduced 57.33%	14,250 $1.02 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $373,385 - $442,563	5,178 Added 18.35%	33,394 $2.71 Million
Q2 2017 Aug 10, 2017	BUY	N/A	28,216	28,216 $2 Million

Others Institutions Holding GILD

# of Institutions

1,892

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $90.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Account

Empirical Finance, LLC Gilead Sciences, Inc. Transaction History